[Treatment of intestinal disorders with Mexase, a new enzyme-combination drug].
D000328:Adult; D000368:Aged; D000681:Amylases; D001963:Bromelains / Q000627:therapeutic use*; D002764:Cholecystitis / Q000188:drug therapy; D002918:Chymotrypsin; D007464:Clioquinol / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010194:Pancreatin / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy; D011804:Quinolines; D014357:Trypsin
D011804:Quinolines; D007464:Clioquinol; D010194:Pancreatin; D001963:Bromelains; D000681:Amylases; D002918:Chymotrypsin; D014357:Trypsin
Therapie intestinaler Störungen mit Mexase, einem neuartigen Ferment-Kombinationspräparat.